Oligoclonal expansion of circulating and tissue-infiltrating CD8 + T Cells with killer/effector phenotypes in juvenile dermatomyositis syndrome

Clinical and Experimental Immunology

Volumn 137, Issue 1, 2004, Pages 187-194

  Mizuno, K ^a   Yachie, A ^a   Nagaoki, S ^a   Wada, H ^a   Okada, K ^a   Kawachi, M ^a   Toma, T ^a   Konno, A ^a   Ohta, K ^a   Kasahara, Y ^a   Koizumi, S ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Cytotoxic T cells; Juvenile dermatomyositis syndrome; T cell receptor complementarity determining region 3

Indexed keywords

MONOCLONAL ANTIBODY; T LYMPHOCYTE RECEPTOR;

ARTICLE; BLOOD; CELL FUNCTION; CELL SUBPOPULATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DERMATOMYOSITIS; EFFECTOR CELL; ELECTROMYOGRAPHY; FLOW CYTOMETRY; GENE AMPLIFICATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; INFLAMMATION; JUVENILE DERMATOMYOSITIS SYNDROME; KILLER CELL; LABORATORY; LYMPHOCYTIC INFILTRATION; MEMORY CELL; MOLECULAR BIOLOGY; MOLECULAR CLONING; MUSCLE BIOPSY; MUSCLE TISSUE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SAMPLE; T LYMPHOCYTE;

ANTIGENS, CD; ANTIGENS, SURFACE; BASE SEQUENCE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHILD; COMPLEMENTARITY DETERMINING REGIONS; DERMATOMYOSITIS; HUMANS; IMMUNOHISTOCHEMISTRY; MUSCLES; PHENOTYPE; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SYNDROME; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, REGULATORY;

EID: 3042785010     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2004.02500.x     Document Type: Article

References (37)

1. Massa M, Costouros N, Mazzoli F et al. Self epitopes shared between human skeletal myosin and streptococcus pyogenes M5 protein are targets of immune responses in active juvenile dermatomyositis. Arthritis Rheum 2002; 46:3015-25.
2. Lehmann H, Kuhner L, Beckenlehner K et al. Chronic human parvovirus B19 infection in rheumatic disease of childhood and adolescence. J Clin Virol 2002; 25:135.
3. Lewkonia RM, Home D, Dawood MR. Juvenile dermatomyositis in a child infected with human parvovirus B19. Clin Infect Dis 1995; 21:430-2.
4. McMurray RW, Elbourne K. Hepatitis C virus infection and autoimmunity. Semin Arthritis Rheum 1997; 26:689-701.
5. Bardelas JA, Winkelstein JA, Seto DS, Tsai T, Rogol AD. Fatal ECHO 24 infection in a patient with hypogammaglobulinemia: relationship to dermatomyositis-like syndrome. J Pediatr 1977; 90:396-9.
6. Comola M, Johnson MA, Howel D, Brunsdon C. Spatial distribution of muscle necrosis in biopsies from patients with inflammatory muscle disorders. J Neurol Sci 1987; 82:229-44.
7. Pachman LM. Juvenile dermatomyositis (JDMS). new clues to diagnosis and pathogenesis. Clin Exp Rheumatol 1994; 12:69-73.
8. Pachman LM. Juvenile dermatomyositis. Pediatr Clin North Am 1986; 33:1097-117.
9. Pachman LM, Hayford JR, Chung A et al. Juvenile dermatomyositis at diagnosis: clinical characteristics of 79 children. J Rheumatol 1998; 25:1198-204.
10. Iannone F, Cauli A, Yanni G et al. T-lymphocyte immunophenotyping in polymyositis and dermatomyositis. Br J Rheumatol 1996; 35:839-45.
11. Rider LG, Miller FW, Targoff IN et al. A broadened spectrum of juvenile myositis. Myositis-specific autoantibodies in children. Arthritis Rheum 1994; 37:1534-8.
12. Mantegazza R, Bernasconi P. Cellular aspects of myositis. Curr Opin Rheumatol 1994; 6:568-74.
13. Kikuchi Y, Koarada S, Tada Y et al. Difference in B cell activation between dermatomyositis and polymyositis: analysis of the expression of RP105 on peripheral blood B cells. Ann Rheum Dis 2001; 60:1137-40.
14. Dalakas MC. Molecular immunology and genetics of inflammatory muscle diseases. Arch Neurol 1998; 55:1509-12.
15. Eisenstein DM, O'Gorman MR, Pachman LM. Correlations between change in disease activity and changes in peripheral blood lymphocyte subsets in patients with juvenile dermatomyositis. J Rheumatol 1997; 24:1830-2.
16. O'Gorman MR, Bianchi L, Zaas D, Corrochano V, Pachman LM. Decreased levels of CD54 (ICAM-1) -positive lymphocytes in the peripheral blood in untreated patients with active juvenile dermatomyositis. Clin Diagn Laboratory Immunol 2000; 7:693-7.
17. Nishio J, Suzuki M, Miyasaka N, Kohsaka H. Clonal biases of peripheral CD8 T cell repertoire directly reflect local inflammation in polymyositis. J Immunol 2001; 167:4051-8.
18. O'Hanlon TP, Dalakas MC, Plotz PH, Miller FW. Predominant TCR-alpha beta variable and joining gene expression by muscle-infiltrating lymphocytes in the idiopathic inflammatory myopathies. J Immunol 1994; 152:2569-76.
19. Saito M, Higuchi I, Saito A et al. Molecular analysis of T cell clono-types in muscle-infiltrating lymphocytes from patients with human T lymphotropic virus type 1 polymyositis. J Infect Dis 2002; 186:1231-41.
20. Benveniste O, Cherin P, Maisonobe T et al. Severe perturbations of the blood T cell repertoire in polymyositis, but not dermatomyositis patients. J Immunol 2001; 167:3521-9.
21. Ohta K, Yachie A, Fujimoto K et al. Tubular injury as a cardinal pathologic feature in human heme oxygenase-1 deficiency. Am J Kidney Dis 2000; 35:863-70.
22. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:156-9.
23. high TCRαβ T cells in vivo. Blood 2002; 100:4090-7.
24. Choi YW, Kotzin B, Herron L, Callahan J, Marrack P, Kappler J. Interaction of staphylococcus aureus toxin 'superantigens' with human T cells. Proc Natl Acad Sci USA 1989; 86:8941-5.
25. Labrecque N, McGrath H, Subramanyam M, Huber BT, Sekaly RP, Human T. cells respond to mouse mammary tumor virus-encoded superantigen: V beta restriction and conserved evolutionary features. J Exp Med 1993; 177:1735-43.
26. + hematopoietic progenitors. Blood 1998; 91:2588-600.
27. Tezak Z, Hoffman EP, Lutz JL et al. Gene expression profiling in DQA1*0501+ children with untreated dermatomyositis: a novel model of pathogenesis. J Immunol 2002; 168:4154-63.
28. Silins SL, Cross SM, Elliott SL et al. Development of Epstein-Ban virus-specific memory T cell receptor clonotypes in acute infectious mononucleosis. J Exp Med 1996; 184:1815-24.
29. Young NS, Maciejewski JP, Sloand E et al. The relationship of aplastic anemia and PNH. Int J Hematol 2002; 76:168-72.
30. Hingorani R, Monteiro J, Furie R et al. Oligoclonality of V beta 3 TCR chains in the CD8* T cell population of rheumatoid arthritis patients. J Immunol 1996; 156:852-8.
31. Nakao S. Identification of novel minor histocompatibility antigens responsible for graft-versus-leukemia (GVL) effect on chronic myeloid leukemia. usefulness of determining the clonotype of T cells associated with GVL effect after donor leukocyte infusion. Int J Hematol 2002; 76:274-6.
32. Zeng W, Nakao S, Takamatsu H et al. Characterization of T-cell repertoire of the bone marrow in immune-mediated aplastic anemia: evidence for the involvement of antigen-driven T-cell response in cyclosporine-dependent aplastic anemia. Blood 1999; 93:3008-16.
33. + T cells contain greatly expanded functional virus-specific memory CTL clones. J Immunol 1999; 162:7569-77.
34. + T-cell population. Immunology 1999; 98:443-9.
35. + T lymphocytes in normal, healthy individuals are oligoclonal and respond to human cytomegalovirus. J Immunol 1995; 155:5046-56.
36. Picker LJ, Treer JR, Ferguson-Darnell B, Collins PA, Buck D, Terstappen LW. Control of lymphocyte recirculation in man. I. Differential regulation of the peripheral lymph node homing receptor 1-selection on T cells during the virgin to memory cell transition. J Immunol 1993; 150:1105-21.
37. Arstila TP, Casrouge A, Baron V, Even J, Kanellopoulos J, Kourilsky P. Diversity of human alpha beta T cell receptors. Science 2000; 288:1135-7.